Recent studies suggest that IL33/IL33Rα is involved in HNSCC carcinogenesis, possibly through both direct effects on the cancer cells and indirect effects via stromal/immunocompetent cells [36,37,38,39]. This evidence concerns the gene IL33 and cancer.